60 DEGREES PHARMACEUTICALS, INC. Long-Term Debt, Maturity, Year Two
60 DEGREES PHARMACEUTICALS, INC. (SXTP) had Long-Term Debt, Maturity, Year Two of $3.32 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2026-08-14
- 2026-06-30: Long-Term Debt, Maturity, Year Two $3.32K.
- 2026-03-31: Long-Term Debt, Maturity, Year Two $3.32K.
- 2025-12-31: Long-Term Debt, Maturity, Year Two $3.23K.
- 2025-09-30: Long-Term Debt, Maturity, Year Two $3.22K.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2026-06-30 | $3.32K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $3.32K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $3.23K 10-K · filed 2026-03-30 |
| 2025-09-30 | $3.22K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $3.22K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $3.22K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $404.00 10-K · filed 2025-03-27 |
| 2024-09-30 | $683.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | $683.00 10-Q · filed 2024-08-14 |
| 2024-03-31 | $683.00 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |